Overslaan en naar de inhoud gaan

 Alle verbonden artikelen

Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast Cancer.

Auteurs : Zardavas D, Piccart-Gebhart M
Jaar : 2015
Journal : Am Soc Clin Oncol Educ Book
Volume : 35
Pagina's : e183-90

Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive and Triple-Negative Primary Breast Cancers.

Auteurs : Denkert C, Von Minckwitz G, Brase JC, Sinn BV, Gade S, Kronenwett R, Pfitzner BM, Salat C, Loi S, Schmitt WD, Schem C, Fisch K, Darb-Esfahani S, Mehta K, Sotiriou C, Wienert S, Klare P, André F, Klauschen F, Blohmer J, Krappmann K, Schmidt M, Tesch H, Kümmel S, Sinn P, Jackisch C, Dietel M, Reimer T, Untch M, Loibl S
Jaar : 2015
Journal : J. Clin. Oncol.
Volume : 33(9)
Pagina's : 983-91

SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma.

Auteurs : El Hajj P, Gilot D, Migault M, Theunis A, Van Kempen LC, Sales F, Fayyad-Kazan H, Badran B, Larsimont D, Awada A, Bachelot L, Galibert MD, Ghanem G, Journe F
Jaar : 2015
Journal : Br J Cancer
Volume : 113(1)
Pagina's : 91-8

Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer.

Auteurs : Boyle FM, Smith IE, + collaborators (among others :, Piccart-Gebhart M, Finkelstein D
Jaar : 2015
Journal : Eur. J. Cancer
Volume : 51(6)
Pagina's : 685-96

New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.

Auteurs : Saiselet M, Gacquer D, Spinette A, Craciun L, Decaussin-Petrucci M, Andry G, Detours V, Maenhaut C
Jaar : 2015
Journal : BMC Genomics
Volume : 16
Pagina's : 828

Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy.

Auteurs : Azim HA, Vingiani A, Peccatori F, Viale G, Loi S, Pruneri G
Jaar : 2015
Journal : Breast
Volume : 24(3)
Pagina's : 290-3

Tailoring therapies - improving the management of early breast cancer: St GallenInternational Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Auteurs : Coates AS, Winer EP, Goldhirsch A, Gelber Rd, Gnant M, Piccart-Gebhart M, Thürlimann B, Senn HJ
Jaar : 2015
Journal : Ann Oncol
Volume : 26(8)
Pagina's : 1533-46

BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis.

Auteurs : Willaert W, Van Der Speeten K, Liberale G, Ceelen W
Jaar : 2015
Journal : BMC Cancer
Volume : 15
Pagina's : 980

A first-in-human phase I and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumours.

Auteurs : Venugopal B, Awada A, Evans TR, Dueland S, Hendlisz A, Rasch W, Hernes K, Hagen S, Aamdal S
Jaar : 2015
Journal : Cancer Chemother Pharmacol
Volume : 76(4)
Pagina's : 785-92

No significant viral transcription detected in whole breast cancer transcriptomes.

Auteurs : Fimereli D, Gacquer D, Fumagalli D, Salgado R, Rothé F, Larsimont D, Sotiriou C, Detours V
Jaar : 2015
Journal : BMC Cancer
Volume : 15(null)
Pagina's : 147

Risk of Misinterpretation of Ebola Virus PCR Results After rVSV ZEBOV-GP Vaccination.

Auteurs : Cnops L, Gerard M, Vandenberg O, Van den Wijngaert S, Heyndrickx L, Willems E, Demeulemeester K, De Clerck H, Dediste A, Callens S, De Munter P, Vlieghe E, Bottieau E, Wuillaume F, Van Esbroeck M, Ariën KK
Jaar : 2015
Journal : Clin Infect Dis
Volume : 60(11)
Pagina's : 1725-26

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

Auteurs : Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA, Ugolini D, Pronzato P, Loibl S, Moore HC, Partridge AH, Bruzzi P, Del Mastro L
Jaar : 2015
Journal : Ann Oncol
Volume : 26
Pagina's : 2408-19

A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck.

Auteurs : Machiels JP, Specenier P, Krauß J, Dietz A, Kaminsky MC, Lalami Y, Henke M, Keilholz U, Knecht R, Skartved NJ, Horak ID, Pamperin P, Braun S, Gauler TC
Jaar : 2015
Journal : Cancer Chemother Pharmacol
Volume : 76(1)
Pagina's : 13-20

Erdheim-Chester Disease: A Case Report.

Auteurs : Alexiou J, Klastersky J
Jaar : 2015
Journal : Am J Case Rep
Volume : 16
Pagina's : 361-6

Novel mechanisms and approaches in the medical therapy of solid cancers.

Auteurs : Awada G, Kourie HR, Awada A
Jaar : 2015
Journal : Discov Med
Volume : 20
Pagina's : 33-41

Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society.

Auteurs : Baron F, Zachée P, Maertens J, Kerre T, Ory A, Seidel L, Graux C, Lewalle P, Van Gelder M, Theunissen K, Willems E, Emonds MP, De Becker A, Beguin Y
Jaar : 2015
Journal : J Hematol Oncol
Volume : 8(1)
Pagina's : 4

What can be learned from our pediatric colleagues?

Auteurs : Klastersky J
Jaar : 2015
Journal : Curr Opin Oncol
Volume : 27
Pagina's : 283-4

Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.

Auteurs : Ju YS, Tubio JM, Mifsud W, Fu B, Davies HR, Ramakrishna M, Li Y, Yates L, Gundem G, Tarpey PS, Behjati S, Papaemmanuil E, Martin S, Fullam A, Gerstung M, Nangalia J, Green AR, Caldas C, Borg Å, Tutt A, Lee MT, van t Veer LJ, Tan BK, Aparicio S, Span PN, Martens JW, Knappskog S, Vincent-Salomon A, Borresen-Dale AL, Eyfjord JE, Flanagan AM, Foster C, Neal DE, Cooper C, Eeles R, Lakhani SR, Desmedt C, Thomas G, Richardson AL, Purdie CA, Thompson AM, McDermott U, Yang F, Nik-Zainal S, Campbell PJ, Stratton MR
Jaar : 2015
Journal : Genome Res
Volume : 25(6)
Pagina's : 814-24

Virulence Factors of Streptococcus pneumoniae. Comparison between African and French Invasive Isolates and Implication for Future Vaccines.

Auteurs : Blumental S, Granger-Farbos A, Moïsi JC, Soullié B, Leroy P, Njanpop-Lafourcade BM, Yaro S, Nacro B, Hallin M, Koeck JL
Jaar : 2015
Journal : PLoS One
Volume : 10(7)
Pagina's : e0133885

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol.

Auteurs : Hendlisz A, Deleporte A, Vandeputte C, Charette N, Paesmans M, Guiot T, Garcia C, Flamen P
Jaar : 2015
Journal : BMJ Open
Volume : 5(3)
Pagina's : e007189